Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28676 - 28700 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	SERPINB9	5272	downregulated	Cytarabine results in decreased expression of SERPINB9 mRNA	6p25.2	A21886
Cytarabine	Approved Investigational	SERPINH1	871	downregulated	Cytarabine results in decreased expression of SERPINH1 mRNA	11q13.5	A21886
Cytarabine	Approved Investigational	SERTAD1	29950	downregulated	Cytarabine results in decreased expression of SERTAD1 mRNA	19q13.1-q13.2	A21886
Cytarabine	Approved Investigational	SFRP1	6422	upregulated	Cytarabine results in increased expression of SFRP1 mRNA	8p11.21	A21886
Cytarabine	Approved Investigational	SFRP2	6423	upregulated	Cytarabine results in increased expression of SFRP2 mRNA	4q31.3	A21886
Cytarabine	Approved Investigational	SGIP1	84251	upregulated	Cytarabine results in increased expression of SGIP1 mRNA	1p31.3	A21886
Cytarabine	Approved Investigational	SH3RF2	153769	downregulated	Cytarabine results in decreased expression of SH3RF2 mRNA	5q32	A21886
Cytarabine	Approved Investigational	SIPA1L2	57568	downregulated	Cytarabine results in decreased expression of SIPA1L2 mRNA	1q42.2	A21886
Cytarabine	Approved Investigational	SLA	6503	upregulated	Cytarabine results in increased expression of SLA mRNA	8q24.22	A20985
Cytarabine	Approved Investigational	SLC16A3	9123	downregulated	Cytarabine results in decreased expression of SLC16A3 mRNA	17q25.3	A21886
Cytarabine	Approved Investigational	SLC16A9	220963	upregulated	Cytarabine results in increased expression of SLC16A9 mRNA	10q21.2	A21886
Cytarabine	Approved Investigational	SLC17A6	57084	upregulated	Cytarabine results in increased expression of SLC17A6 mRNA	11p14.3	A21886
Cytarabine	Approved Investigational	SLC2A1	6513	downregulated	Cytarabine results in decreased expression of SLC2A1 mRNA	1p34.2	A21886
Cytarabine	Approved Investigational	SLC39A2	29986	downregulated	Cytarabine results in decreased expression of SLC39A2 mRNA	14q11.2	A21886
Cytarabine	Approved Investigational	SLC40A1	30061	downregulated	Cytarabine results in decreased expression of SLC40A1 mRNA	2q32.2	A21886
Cytarabine	Approved Investigational	SLC43A3	29015	upregulated	Cytarabine results in increased expression of SLC43A3 mRNA	11q12.1	A20985
Cytarabine	Approved Investigational	SLC47A1	55244	downregulated	Cytarabine results in decreased expression of SLC47A1 mRNA	17p11.2	A21886
Cytarabine	Approved Investigational	SLC4A8	9498	downregulated	Cytarabine results in decreased expression of SLC4A8 mRNA	12q13.13	A21886
Cytarabine	Approved Investigational	SLC5A12	159963	downregulated	Cytarabine results in decreased expression of SLC5A12 mRNA	11p14.2	A21886
Cytarabine	Approved Investigational	SLC7A2	6542	downregulated	Cytarabine results in decreased expression of SLC7A2 mRNA	8p22	A21886
Cytarabine	Approved Investigational	SLC7A7	9056	downregulated	Cytarabine results in decreased expression of SLC7A7 mRNA	14q11.2	A21886
Cytarabine	Approved Investigational	SLC9A3R1	9368	downregulated	Cytarabine results in decreased expression of SLC9A3R1 mRNA	17q25.1	A21886
Cytarabine	Approved Investigational	SLFN11	91607	upregulated	Cytarabine results in increased expression of SLFN11 mRNA	17q12	A21886
Cytarabine	Approved Investigational	SLIT2	9353	downregulated	Cytarabine results in decreased expression of SLIT2 mRNA	4p15.31	A21886
Cytarabine	Approved Investigational	SLITRK3	22865	downregulated	Cytarabine results in decreased expression of SLITRK3 mRNA	3q26.1	A21886

Displaying entries 28676 - 28700 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability